相关实验视频

Updated: Sep 12, 2025

Flow Cytometric Analysis of Mitochondrial Reactive Oxygen Species in Murine Hematopoietic Stem and Progenitor Cells and MLL-AF9 Driven Leukemia

Flow Cytometric Analysis of Mitochondrial Reactive Oxygen Species in Murine Hematopoietic Stem and Progenitor Cells and MLL-AF9 Driven Leukemia

Published on: September 5, 2019

在氧化应激下,Jab1促进了急性髓性白血病模型中的免疫逃避和进展

Nan Zhang¹, Qian Wang¹, Guopeng Chen¹

¹Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, China.

The Journal of clinical investigation

|August 5, 2025

概括

在急性髓性白血病 (AML) 中,Jab1通过促进氧化应激和免疫检查点表达来驱动免疫逃避. 用CSN5i-3准Jab1恢复了免疫监测,阻止了AML的进展,并提供了新的治疗策略.

科学领域:

血液学血液学血液学
癌症免疫学癌症免疫学
分子生物学分子生物学

背景情况:

急性髓性白血病 (AML) 是一种流行的血液性恶性瘤.
白血病干细胞面临氧化应激,产生诱导Jab1表达的活性氧物种 (ROS).
作为c-JUN联合激活剂的Jab1在氧化应激下促进AML的进展,但其在免疫逃避中的作用尚不清楚.

研究的目的:

调查Jab1在AML免疫逃避中的作用.
阐明Jab1影响免疫逃避的分子机制.
评估针对AML中的Jab1途径的治疗潜力.

主要方法:

在体内进行基因淘汰研究 (Jab1删除).
免疫检查点表达的分析.
研究涉及LILRB4mRNA的c-JUN,IGF2BP3和m6A修饰的下游信号通路.
使用CSN5i-3.3进行Jab1的药理抑制.

主要成果:

删除Jab1减少了免疫检查点的表达,并在体内克服了AML免疫逃避.
删除Jab1并没有影响正常的造血细胞成熟.
Jab1通过c-JUN激活IGF2BP3,调节LILRB4mRNA的m6A修饰并促进免疫逃避.
CSN5i-3破坏了Jab1通路,恢复了免疫监测,并阻止了AML的进展.

结论:

在AML生存和免疫逃避中,Jab1起着至关重要的作用.
用CSN5i-3针对Jab1是一个有前途的AML治疗策略.
了解Jab1-IGF2BP3-LILRB4轴为AML免疫逃避机制提供了新的见解.

关键词:

癌症基因治疗的基因疗法细胞生物学细胞生物学血液学血液学血液学在白血病中,白血病.信号传导传导是指信号的传导.

更多相关视频

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Assessment of the Metabolic Profile of Primary Leukemia Cells

Published on: November 21, 2018

相关概念视频

Differentiation of Common Myeloid Progenitor Cells

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

Regulation of Hematopoietic Stem Cells

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...

Cancer Stem Cells and Tumor Maintenance

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

B Cell Activation and Differentiation

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...

Disorders of Leukocytes

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...